Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
NurExone Biologic: Erfahren Sie mehr über den Biotech-Gral!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
419 Leser
Artikel bewerten:
(2)

Arix Bioscience PLC: PDMR Notification & Director Shareholding

DJ PDMR Notification & Director Shareholding

Arix Bioscience PLC (ARIX) 
PDMR Notification & Director Shareholding 
02-Nov-2023 / 18:20 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
Arix Bioscience plc 
("Company") 
PDMR Notification & Director Shareholding 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons 
closely associated with them 
The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 60,000 Ordinary 
shares of 0.001 pence each in the Company ("Shares") on 2nd November 2023 at a price of GBP1.1469 per share. 
1       Details of the person discharging managerial responsibilities / person closely associated 
 
a)      Name 
                                     Peregrine Moncreiffe 
 
2       Reason for the notification 
 
a)      Position/status                       Non-Executive Director and Chair of the 
                                     Board 
 
b)      Initial notification /Amendment 
                                     Initial Notification 
 
3       Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction 
       monitor 
 
a)      Name 
                                     Arix Bioscience plc 
 
b)      LEI                             213800OVT3AHQCXNIX43 
 
4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
a)      Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001 
                                     pence each 
 
       Identification code                     GB00BD045071 
b)      Nature of the transaction 
                                     Share purchase 
 
       Price(s) and volume(s)                      Price(s)GBP    Volume(s) 
 c)                                               60,000 
                                        1.1469 
 
       Aggregated information 
d) 
       - Aggregated volume                     60,000 
 
       - Price                           GBP68,815.20 
e)      Date of the transaction 
                                     2 November 2023 
 
f)      Place of the transaction 
                                     Outside a trading venue 
 

For further information please contact: Kin Company Secretarial Limited, Company Secretary +44 20 8819 6486

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BD045071 
Category Code: DSH 
TIDM:      ARIX 
LEI Code:    213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:  282417 
EQS News ID:  1764141 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1764141&application_name=news

(END) Dow Jones Newswires

November 02, 2023 14:20 ET (18:20 GMT)

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2023 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.